임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

35건 표시

3상모집 중단 (진행 중)· Cardiomyopathy, Hypertrophic
A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
리드: BMS
상세 →NCT06253221
3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell Lung
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
리드: BMS
상세 →NCT06140836
3상모집 중단 (진행 중)· Progressive Pulmonary Fibrosis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
리드: BMS
상세 →NCT06025578
3상모집 중단 (진행 중)· Myelodysplastic Syndromes
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
리드: BMS
상세 →NCT05949684
3상모집 중단 (진행 중)· Multiple Myeloma
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
협력: BMS
상세 →NCT06045806
3상모집 중단 (진행 중)· Myelodysplastic Syndromes
A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
리드: BMS
상세 →NCT06045689
3상모집 중단 (진행 중)· Idiopathic Pulmonary Fibrosis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
리드: BMS
상세 →NCT06003426
3상모집 중단 (진행 중)· Sjögren's Syndrome
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
리드: BMS
상세 →NCT05946941
3상모집 중단 (진행 중)· Multiple Myeloma
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
리드: BMS
상세 →NCT05827016
3상모집 중단 (진행 중)· Atrial Fibrillation
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
리드: 얀센(J&J) · 협력: BMS
상세 →NCT05757869
3상모집 중단 (진행 중)· Melanoma
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
리드: BMS
상세 →NCT05625399
3상모집 중단 (진행 중)· Ischemic Stroke; Ischemic Attack, Transient
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
리드: 얀센(J&J) · 협력: BMS
상세 →NCT05702034
3상모집 중단 (진행 중)· Systemic Lupus Erythematosus
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
리드: BMS
상세 →NCT05617677
3상모집 중단 (진행 중)· Systemic Lupus Erythematosus
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
리드: BMS
상세 →NCT05620407
3상모집 중단 (진행 중)· Relapsed or Refractory Multiple Myeloma
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
리드: BMS
상세 →NCT05552976
3상모집 중단 (진행 중)· IgG4 Related Disease
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
협력: BMS
상세 →NCT05662241
3상모집 중단 (진행 중)· Multiple Myeloma
MInimal Residual Disease Adapted Strategy
협력: 암젠, BMS, 사노피
상세 →NCT04934475
3상모집 중단 (진행 중)· Rheumatoid Arthritis
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
리드: BMS
상세 →NCT04909801
3상모집 중단 (진행 중)· Unresectable or Metastatic Melanoma
Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
협력: BMS
상세 →NCT04674683
3상모집 중단 (진행 중)· Psoriatic Arthritis
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment
리드: BMS
상세 →NCT04908189
3상모집 중단 (진행 중)· Psoriatic Arthritis
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
리드: BMS
상세 →NCT04908202
3상모집 중단 (진행 중)· Malignant Melanoma Stage III
Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
협력: BMS
상세 →NCT04949113
3상모집 중단 (진행 중)· Clear Cell Renal Cell Carcinoma
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
리드: BMS
상세 →NCT04810078
3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell Lung
A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
리드: BMS
상세 →NCT04025879
3상모집 중단 (진행 중)· Melanoma
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
리드: BMS
상세 →NCT04099251
3상모집 중단 (진행 중)· Hepatocellular Carcinoma
A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma
리드: BMS
상세 →NCT04039607
3상모집 중단 (진행 중)· Psoriasis
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
리드: BMS
상세 →NCT04036435
3상모집 중단 (진행 중)· Metastatic Colorectal Cancer
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
리드: BMS
상세 →NCT04008030
3상모집 중단 (진행 중)· Renal Cell Carcinoma
A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
리드: BMS
상세 →NCT03873402
3상모집 중단 (진행 중)· Urinary Bladder Neoplasms
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
리드: BMS
상세 →NCT03661320
3상모집 중단 (진행 중)· Epithelial Ovarian Cancer
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
협력: BMS
상세 →NCT03522246
3상모집 중단 (진행 중)· Hepatocellular Carcinoma
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
리드: BMS
상세 →NCT03383458
3상모집 중단 (진행 중)· Renal Cell Carcinoma
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
리드: BMS
상세 →NCT03141177
3상모집 중단 (진행 중)· Urothelial Cancer
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
리드: BMS
상세 →NCT03036098
3상모집 중단 (진행 중)· Various Advanced Cancer
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
리드: BMS
상세 →NCT02632409

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.